These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 36798052)

  • 1. The biological role of prolyl oligopeptidase and the procognitive potential of its peptidic inhibitors from food proteins.
    Taraszkiewicz A; Sinkiewicz I; Sommer A; Staroszczyk H
    Crit Rev Food Sci Nutr; 2024; 64(19):6567-6580. PubMed ID: 36798052
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prolyl oligopeptidase and its role in the organism: attention to the most promising and clinically relevant inhibitors.
    Babkova K; Korabecny J; Soukup O; Nepovimova E; Jun D; Kuca K
    Future Med Chem; 2017 Jun; 9(10):1015-1038. PubMed ID: 28632451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative analysis of the substrate preferences of two post-proline cleaving endopeptidases, prolyl oligopeptidase and fibroblast activation protein α.
    Jambunathan K; Watson DS; Endsley AN; Kodukula K; Galande AK
    FEBS Lett; 2012 Jul; 586(16):2507-12. PubMed ID: 22750443
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prolyl oligopeptidase family.
    Polgár L
    Cell Mol Life Sci; 2002 Feb; 59(2):349-62. PubMed ID: 11915948
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quantitative structure-activity relationship of prolyl oligopeptidase inhibitory peptides derived from beta-casein using simple amino acid descriptors.
    Pripp AH
    J Agric Food Chem; 2006 Jan; 54(1):224-8. PubMed ID: 16390203
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and evaluation of peptide-based prolyl oligopeptidase inhibitors--introduction of N-benzyloxycarbonyl-prolyl-3-fluoropyrrolidine as a lead in inhibitor design.
    Goossens F; Vanhoof G; De Meester I; Augustyns K; Borloo M; Tourwe D; Haemers A; Scharpé S
    Eur J Biochem; 1997 Nov; 250(1):177-83. PubMed ID: 9432007
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolyl peptidases: a serine protease subfamily with high potential for drug discovery.
    Rosenblum JS; Kozarich JW
    Curr Opin Chem Biol; 2003 Aug; 7(4):496-504. PubMed ID: 12941425
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Issues about the physiological functions of prolyl oligopeptidase based on its discordant spatial association with substrates and inconsistencies among mRNA, protein levels, and enzymatic activity.
    Myöhänen TT; García-Horsman JA; Tenorio-Laranga J; Männistö PT
    J Histochem Cytochem; 2009 Sep; 57(9):831-48. PubMed ID: 19687473
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluorescence resonance energy transfer (FRET) peptides and cycloretro-inverso peptides derived from bradykinin as substrates and inhibitors of prolyl oligopeptidase.
    Gorrão SS; Hemerly JP; Lima AR; Melo RL; Szeltner Z; Polgár L; Juliano MA; Juliano L
    Peptides; 2007 Nov; 28(11):2146-54. PubMed ID: 17904692
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of DPP-IV inhibitory peptides derived from buffalo colostrum: Mining through bioinformatics, in silico and in vitro approaches.
    Ashok A; H S A
    J Mol Recognit; 2024 Jul; 37(4):e3090. PubMed ID: 38803118
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting inhibition of fibroblast activation protein-α and prolyl oligopeptidase activities on cells common to metastatic tumor microenvironments.
    Christiansen VJ; Jackson KW; Lee KN; Downs TD; McKee PA
    Neoplasia; 2013 Apr; 15(4):348-58. PubMed ID: 23555181
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An endo-acting proline-specific oligopeptidase from Treponema denticola ATCC 35405: evidence of hydrolysis of human bioactive peptides.
    Mäkinen PL; Mäkinen KK; Syed SA
    Infect Immun; 1994 Nov; 62(11):4938-47. PubMed ID: 7523301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolyl oligopeptidase induces angiogenesis both in vitro and in vivo in a novel regulatory manner.
    Myöhänen TT; Tenorio-Laranga J; Jokinen B; Vázquez-Sánchez R; Moreno-Baylach MJ; García-Horsman JA; Männistö PT
    Br J Pharmacol; 2011 Aug; 163(8):1666-78. PubMed ID: 21133893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modulating the selectivity of inhibitors for prolyl oligopeptidase inhibitors and fibroblast activation protein-α for different indications.
    Plescia J; Hédou D; Pousse ME; Labarre A; Dufresne C; Mittermaier A; Moitessier N
    Eur J Med Chem; 2022 Oct; 240():114543. PubMed ID: 35797897
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure, function and biological relevance of prolyl oligopeptidase.
    Szeltner Z; Polgár L
    Curr Protein Pept Sci; 2008 Feb; 9(1):96-107. PubMed ID: 18336325
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Substrate-dependent, non-hyperbolic kinetics of pig brain prolyl oligopeptidase and its tight binding inhibition by JTP-4819.
    Venäläinen JI; Juvonen RO; Forsberg MM; Garcia-Horsman A; Poso A; Wallen EA; Gynther J; Männistö PT
    Biochem Pharmacol; 2002 Aug; 64(3):463-71. PubMed ID: 12147298
    [TBL] [Abstract][Full Text] [Related]  

  • 17. OsPOP5, a prolyl oligopeptidase family gene from rice confers abiotic stress tolerance in Escherichia coli.
    Tan CM; Chen RJ; Zhang JH; Gao XL; Li LH; Wang PR; Deng XJ; Xu ZJ
    Int J Mol Sci; 2013 Oct; 14(10):20204-19. PubMed ID: 24152437
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prolyl oligopeptidase is inhibited in relapsing-remitting multiple sclerosis.
    Tenorio-Laranga J; Coret-Ferrer F; Casanova-Estruch B; Burgal M; García-Horsman JA
    J Neuroinflammation; 2010 Apr; 7():23. PubMed ID: 20370893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The prolyl oligopeptidase inhibitor IPR19 ameliorates cognitive deficits in mouse models of schizophrenia.
    Prades R; Munarriz-Cuezva E; Urigüen L; Gil-Pisa I; Gómez L; Mendieta L; Royo S; Giralt E; Tarragó T; Meana JJ
    Eur Neuropsychopharmacol; 2017 Feb; 27(2):180-191. PubMed ID: 27986355
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The prolyl oligopeptidase inhibitor SUAM-14746 attenuates the proliferation of human breast cancer cell lines in vitro.
    Tanaka S; Suzuki K; Sakaguchi M
    Breast Cancer; 2017 Sep; 24(5):658-666. PubMed ID: 28070831
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.